These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9754735)

  • 21. Vagal dysfunction and impaired urinary sodium and water excretion in cirrhosis.
    Hendrickse MT; Triger DR
    Am J Gastroenterol; 1994 May; 89(5):750-7. PubMed ID: 8172151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity.
    Wong F; Logan A; Blendis L
    Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Free water clearance after supplemental albumin resuscitation for shock.
    Moon MR; Lucas CE; Ledgerwood AM; Kosinski JP
    Circ Shock; 1989 May; 28(1):1-8. PubMed ID: 2731318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis.
    Bichet DG; Van Putten VJ; Schrier RW
    N Engl J Med; 1982 Dec; 307(25):1552-7. PubMed ID: 6755251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of norepinephrine on plasma vasopressin concentration and renal water metabolism.
    Kimura T; Wang BC; Crofton JT; Share L
    Neuroendocrinology; 1980 Oct; 31(4):276-81. PubMed ID: 7422068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites.
    Guyader D; Patat A; Ellis-Grosse EJ; Orczyk GP
    Hepatology; 2002 Nov; 36(5):1197-205. PubMed ID: 12395330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis.
    Inoue T; Ohnishi A; Matsuo A; Kawai B; Kunihiro N; Tada Y; Koizumi F; Chau T; Okada K; Yamamura Y; Tanaka T
    Clin Pharmacol Ther; 1998 May; 63(5):561-70. PubMed ID: 9630829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal tubular sodium and water excretion in antibiotic-induced nephrotoxicity. Renal function in antibiotic nephrotoxicity.
    Hsu CH; Maletz RM; Rozas VV; Kurtz TW
    Nephron; 1978; 20(4):227-34. PubMed ID: 634420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of plasma vasopressin in the impairment of water excretion in nephrotic syndrome.
    Usberti M; Federico S; Meccariello S; Cianciaruso B; Balletta M; Pecoraro C; Sacca L; Ungaro B; Pisanti N; Andreucci VE
    Kidney Int; 1984 Feb; 25(2):422-9. PubMed ID: 6727137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
    Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
    Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arterial underfilling does not cause sodium retention in cirrhosis.
    Rector WG; Robertson AD; Lewis FW; Adair OV
    Am J Med; 1993 Sep; 95(3):286-95. PubMed ID: 8368226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary excretion of urodilatin in patients with cirrhosis.
    Saló J; Jiménez W; Kuhn M; Ginès A; Ginès P; Fernández-Esparrach G; Angeli P; Clària J; Bataller R; Arroyo V; Forssmann WG; Rodés J
    Hepatology; 1996 Dec; 24(6):1428-32. PubMed ID: 8938175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary kallikrein excretion in chronic liver disease and effect of indomethacin.
    Kawasaki H; Murawaki Y; Hirayama C
    Am J Gastroenterol; 1986 Jan; 81(1):67-70. PubMed ID: 3510529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of endothelin in cirrhosis.
    Asbert M; Ginès A; Ginès P; Jiménez W; Clària J; Saló J; Arroyo V; Rivera F; Rodés J
    Gastroenterology; 1993 May; 104(5):1485-91. PubMed ID: 8482460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
    Decaux G
    J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reabsorption of sodium in the proximal renal tubule in cirrhosis of the liver.
    Chiandussi L; Bartoli E; Arras S
    Gut; 1978 Jun; 19(6):497-503. PubMed ID: 680584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of angiotensin II on renal water excretion.
    Cadnapaphornchai P; Boykin J; Harbottle JA; McDonald KM; Schrier RW
    Am J Physiol; 1975 Jan; 228(1):155-9. PubMed ID: 1147006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of water immersion on plasma catecholamines in decompensated cirrhosis. Implications for deranged sodium and water homeostasis.
    Epstein M; Larios O; Johnson G
    Miner Electrolyte Metab; 1985; 11(1):25-34. PubMed ID: 3883119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.